LOS ANGELES, CA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)CURESHANK, founded in 2019, is a small nonprofit in the Medical Research sector that reported $465K in total revenue in fiscal year 2023. The organization ran a surplus of $177K, a strong 38% operating margin.
TO ACCELERATE THE DEVELOPMENT OF TREATMENTS FOR PHELAN-MCDERMID SYNDROME AND SHANK-RELATED DISORDERS.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $464,972 | $487,302 | 0.0% |
| Expenses | $287,968 | $219,660 | +0.3% |
| Net Income | $177,004 | $267,642 | -0.3% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| GERALDINE BLISS | PRESIDENT | 50.00 |
Officer
Director
|
$0 | $0 | $0 |
| PAULINA RYCHENKOVA | SECRETARY | 5.00 |
Officer
Director
|
$0 | $0 | $0 |
| ABBY LIEVENSE | TREASURER | 15.00 |
Officer
Director
|
$0 | $0 | $0 |
| TALYA EMERY SILVA | VICE PRESIDENT | 35.00 |
Officer
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | No data | No data | No data | No data |
| 2023 | $464,972 | $287,968 | $1,042,385 | $177,004 |
| 2022 | $487,302 | $219,660 | $854,048 | $267,642 |
| 2021 | $547,552 | $18,174 | $586,406 | $529,378 |
Compare CURESHANK with other nonprofits in California and across the country.